top of page
Business Meeting

Clinical Trials and Market Access

Clinical trials and securing market access are vital components in bringing a medical device to market. This guide will walk you through the essential steps for conducting clinical trials and gaining market access in the EU and US. It includes key information on regulatory approvals, trial design, and strategies to enter both markets, with helpful links provided for each step.

Step 1:

Understand Regulatory Requirements for Clinical Trials

Before you initiate clinical trials, it's essential to understand the regulatory framework that governs these trials in both the EU and US.

In the EU:

Clinical trials for medical devices are governed under the EU MDR and IVDR. Clinical investigations are required for most Class IIa, IIb, and III devices to prove their safety and performance before obtaining a CE mark.

More info:

In the US:

Clinical trials for medical devices fall under the FDA’s Investigational Device Exemption (IDE) framework. Depending on the classification and intended use of the device, trials may be required as part of the 510(k) or PMA approval process.

More info:

  • FDA Investigational Device Exemption (IDE)

Step 2:

Design Your Clinical Trial

Designing your clinical trial is a crucial step to ensure that your study generates the evidence needed to meet regulatory standards. Trial design must follow Good Clinical Practice (GCP) guidelines and should be appropriately powered to demonstrate both safety and efficacy.

Key Design Elements:

  • Objective: Clearly define the trial’s goals, such as proving efficacy or confirming safety.

  • Sample Size: Calculate the number of participants needed for statistical significance.

  • Endpoints: Choose appropriate clinical endpoints that align with regulatory expectations.

  • Control Group: Consider using a control group or comparative device.

Useful links for clinical trial design:

Step 3:

Submit Your Trial for Regulatory Approval

Before you begin your clinical trial, you must receive approval from regulatory authorities and ethics committees.

In the EU:

Manufacturers need approval from both the national Competent Authority (CA) and an ethics committee. The trial must also be registered in the EUDAMED database (for MDR/IVDR-compliant studies).

More info:

In the US:

Submit an Investigational Device Exemption (IDE) to the FDA if your device requires premarket approval. In some cases, clinical trials must also be registered on ClinicalTrials.gov.

More info:

Step 4:

Conduct the Clinical Trial

After receiving regulatory approval, the next step is to conduct the clinical trial according to the approved protocol. Regular monitoring, data collection, and adherence to Good Clinical Practice (GCP) guidelines are critical to ensure valid and reliable results.

Important Considerations:

  • Monitoring: Ensure independent monitoring to check protocol compliance and participant safety.

  • Data Management: Implement robust systems for managing clinical data, ensuring quality and accuracy.

  • Safety Reporting: Report adverse events and incidents to regulatory authorities promptly.

For more guidance on trial conduct:

Step 5:

Analyze Data and Prepare a Clinical Evaluation Report

Once your trial is completed, analyze the data to determine whether the device meets the safety and performance criteria. This analysis forms the basis of your Clinical Evaluation Report (CER) in the EU or your submission to the FDA.

In the EU (MDR/IVDR):

Prepare a Clinical Evaluation Report (CER) that demonstrates the clinical benefits and safety of your device, as required by MDR Annex XIV. This report must be included in your technical documentation for CE marking.

More information:

In the US (FDA):

Submit the clinical trial results as part of your 510(k) or PMA application, depending on the classification of your device.

More info:

  • FDA 510(k) Submission Requirements

  • FDA PMA Application Process

Step 6:

Achieve Regulatory Approval and Market Access

After submitting your trial data and technical documentation, the final step is to achieve regulatory approval and enter the market.

In the EU:

Once the clinical evaluation report is approved and compliance with MDR/IVDR is demonstrated, you can apply for the CE mark. With the CE mark, your device can be marketed throughout the European Economic Area (EEA).

More information:

In the US:

After FDA approval through the 510(k) or PMA process, you can market your device in the United States. Additionally, you must ensure compliance with ongoing FDA regulations, such as post-market surveillance and reporting requirements.

More information:

  • FDA Device Approval Process

Step 7:

Post-Market Surveillance and Ongoing Compliance

After gaining market access, manufacturers must continue monitoring their devices’ performance and safety through post-market surveillance (PMS) and vigilance systems.

In the EU:

A post-market surveillance plan is mandatory for all medical devices under MDR/IVDR. Regular safety updates, risk analysis, and performance reviews are required to maintain compliance.

More information:

In the US:

Post-market surveillance is required for certain devices. The FDA mandates reporting of adverse events and device malfunctions through the Medical Device Reporting (MDR) system.

More information:

  • FDA Post-Market Surveillance Requirements

Helpful Links:

bottom of page